Visual Acuity Reduced Transiently
6
0
0
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
33.3%
2 terminated out of 6 trials
66.7%
-19.8% vs benchmark
33%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
The Incidence of Glistenings in the 2017 Intraocular Lenses Made by Alcon and Abbott Medical Optics
Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause
Home-based Visual Training in Patients Implanted With Trifocal Diffractive Intraocular Lenses
Changes in Power and Cylinder Axis of Toric Soft Contact Lenses (LKL)
Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.